Castle Biosciences (NASDAQ:CSTL) Research Coverage Started at Guggenheim
Guggenheim assumed coverage on shares of Castle Biosciences (NASDAQ:CSTL – Free Report) in a report issued on Thursday, MarketBeat.com reports. The firm issued a buy rating and a $25.00 price target on the stock. Castle Biosciences Stock Down 2.6 % Shares of Castle Biosciences stock opened at $20.07 on Thursday. The firm has a market […]
More Stories
Rocket Lab USA, Inc. (NASDAQ:RKLB) Director Matthew Ocko Sells 2,000,000 Shares
Rocket Lab USA, Inc. (NASDAQ:RKLB – Get Free Report) Director Matthew Ocko sold 2,000,000 shares of the firm’s stock in...
Viant Technology Inc. (NASDAQ:DSP) CFO Larry Madden Sells 67,243 Shares
Viant Technology Inc. (NASDAQ:DSP – Get Free Report) CFO Larry Madden sold 67,243 shares of the firm’s stock in a...
Plymouth Industrial REIT, Inc. (NYSE:PLYM) Director Buys $91,950.00 in Stock
Plymouth Industrial REIT, Inc. (NYSE:PLYM – Get Free Report) Director Pendleton P. Jr. White purchased 5,000 shares of the business’s...
GoPro, Inc. (NASDAQ:GPRO) Short Interest Down 8.9% in October
GoPro, Inc. (NASDAQ:GPRO – Get Free Report) was the recipient of a significant decline in short interest during the month...
Hanover Bancorp, Inc. (NASDAQ:HNVR) Short Interest Update
Hanover Bancorp, Inc. (NASDAQ:HNVR – Get Free Report) was the recipient of a large growth in short interest during the...
Infobird Co., Ltd (NASDAQ:IFBD) Short Interest Down 13.8% in October
Infobird Co., Ltd (NASDAQ:IFBD – Get Free Report) was the target of a significant drop in short interest in October....